Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast.
5 affiliations
- 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, SE- 17177, Sweden. [email protected].
- 2Department of Surgery, Capio St. Göran's Hospital, Stockholm, Sweden. [email protected].
- 3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, SE- 17177, Sweden.
- 4Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- 5Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
Abstract
Purpose
Breast conservation for invasive breast cancer is associated with better survival and fewer complications than mastectomy, which is especially relevant for older patients. It is unclear whether this can be extrapolated to ductal carcinoma in situ (DCIS).Methods
This population-based cohort study used data from the Breast Cancer Database Sweden (BCBaSe 3.0) to compare overall survival (OS), breast cancer-specific survival (BCSS) and local recurrence (LR) probabilities in three different age groups (< 60, 60-69, 70 + years) of women with primary DCIS undergoing breast-conserving surgery with radiotherapy (BCS + RT), mastectomy without radiotherapy (Mx-RT), or breast-conserving surgery without radiotherapy (BCS-RT) during 2008-2019. Complete cases (CC) and multiple imputation (MI) analyses were applied.Results
In 7165 women, treatment was BCS + RT (53.3%), BCS-RT (13.4%), or Mx-RT (33.2%). Estimated 10-year OS was 90.4% (95% CI 89.3-91.5) and BCSS 98.8% (98.3-99.2). After adjustments for patient and tumour factors, including socioeconomic status and comorbidity, Mx-RT was associated with a higher overall mortality than BCS + RT in CC (HR 2.10; 95% CI 1.20-3.67) but not in MI analyses (HR 1.29; 0.95-1.76). In age 70 + years, however, the overall mortality was consistently increased (CC: HR 2.48; 1.09-5.62, MI: HR 1.89; 1.23-2.90). Also BCS-RT was associated with a higher overall mortality than BCS + RT (CC: HR 2.68; 1.34-5.34, and MI: HR 1.72; 1.23-2.39). The 10-year LR probability was low (7.2%, 95% CI 6.3-8.0). Compared to BCS + RT, Mx-RT was associated with a lower (HR 0.18, 95% CI 0.11-0.28) and BCS-RT with a higher LR risk (HR 1.79; 1.31-2.46), especially among ages 70+.Conclusion
BCS + RT in DCIS appears safe. Acknowledging potential selection bias, BCS + RT may be associated with favourable overall survival outcomes in older women despite a higher risk of local recurrence.
Related
- Case Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma
- Long-term oncological outcomes after nipple-sparing mastectomy and implant-based immediate breast reconstruction in a population-based cohort of breast cancer patients
- Development and internal validation of a machine learning prediction model for postoperative hemorrhage following modified radical mastectomy for breast cancer
- Comparison of surgical outcomes, safety, and cosmetic satisfaction between immediate implant-based and transverse rectus abdominis myocutaneous (TRAM) flap breast reconstruction following total mastectomy: a retrospective cohort study
- Peritumoral SULF1 Transcript Signal Is Associated with Disease-Specific Survival in Oral Squamous Cell Carcinoma
BibTeX
@article{boniface2026agespecific,
title = {{Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast.}},
author = {Jana de Boniface and Robert Szulkin and Per Karlsson and Anna L V Johansson},
journal = {Breast cancer research and treatment},
year = {2026},
month = oct,
doi = {10.1007/s10549-026-08097-y},
url = {https://europepmc.org/article/MED/42902063},
note = {CC BY},
}
RIS
TY - JOUR
TI - Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast.
AU - Jana de Boniface
AU - Robert Szulkin
AU - Per Karlsson
AU - Anna L V Johansson
PY - 2026
DA - 2026/10/20
JO - Breast cancer research and treatment
DO - 10.1007/s10549-026-08097-y
UR - https://europepmc.org/article/MED/42902063
AB - Purpose Breast conservation for invasive breast cancer is associated with better survival and fewer complications than mastectomy, which is especially relevant for older patients. It is unclear whether this can be extrapolated to ductal carcinoma in situ (DCIS).Methods This population-based cohort study used data from the Breast Cancer Database Sweden (BCBaSe 3.0) to compare overall survival (OS), breast cancer-specific survival (BCSS) and local recurrence (LR) probabilities in three different age groups (< 60, 60-69, 70 + years) of women with primary DCIS undergoing breast-conserving surgery with radiotherapy (BCS + RT), mastectomy without radiotherapy (Mx-RT), or breast-conserving surgery without radiotherapy (BCS-RT) during 2008-2019. Complete cases (CC) and multiple imputation (MI) analyses were applied.Results In 7165 women, treatment was BCS + RT (53.3%), BCS-RT (13.4%), or Mx-RT (33.2%). Estimated 10-year OS was 90.4% (95% CI 89.3-91.5) and BCSS 98.8% (98.3-99.2). After adjustments for patient and tumour factors, including socioeconomic status and comorbidity, Mx-RT was associated with a higher overall mortality than BCS + RT in CC (HR 2.10; 95% CI 1.20-3.67) but not in MI analyses (HR 1.29; 0.95-1.76). In age 70 + years, however, the overall mortality was consistently increased (CC: HR 2.48; 1.09-5.62, MI: HR 1.89; 1.23-2.90). Also BCS-RT was associated with a higher overall mortality than BCS + RT (CC: HR 2.68; 1.34-5.34, and MI: HR 1.72; 1.23-2.39). The 10-year LR probability was low (7.2%, 95% CI 6.3-8.0). Compared to BCS + RT, Mx-RT was associated with a lower (HR 0.18, 95% CI 0.11-0.28) and BCS-RT with a higher LR risk (HR 1.79; 1.31-2.46), especially among ages 70+.Conclusion BCS + RT in DCIS appears safe. Acknowledging potential selection bias, BCS + RT may be associated with favourable overall survival outcomes in older women despite a higher risk of local recurrence.
SN - 0167-6806
SN - 1573-7217
ER -